There was no difference between the two groups in the APACHE II or Charlson score, the number of days of hospitalization and of ICU stay prior to A. baumannii bacteremia, individual underlying disease such as leukemia or lymphoma, immunosuppressant, foci of infection, or initial laboratory data except lower platelet counts in the nonsurvivors.